GNMKGenMark Diagnostics, Inc.

Nasdaq www.genmarkdx.com


$ 24.05 $ 0.00 (0 %)    

Wednesday, 21-Apr-2021 15:59:57 EDT
QQQ $ 480.84 $ -1.29 (-0.27 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 24.04
$ 0.00 x 0
$ 0.00 x 0
-- - --
$ 8.42 - $ 24.25
3,825,678
na
1.76B
$ 0.72
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-25-2021 12-31-2020 10-K
2 10-28-2020 09-30-2020 10-Q
3 08-04-2020 06-30-2020 10-Q
4 05-04-2020 03-31-2020 10-Q
5 03-02-2020 12-31-2019 10-K
6 11-06-2019 09-30-2019 10-Q
7 08-05-2019 06-30-2019 10-Q
8 04-30-2019 03-31-2019 10-Q
9 02-25-2019 12-31-2018 10-K
10 10-30-2018 09-30-2018 10-Q
11 07-30-2018 06-30-2018 10-Q
12 05-01-2018 03-31-2018 10-Q
13 02-27-2018 12-31-2017 10-K
14 11-02-2017 09-30-2017 10-Q
15 08-01-2017 06-30-2017 10-Q
16 05-02-2017 03-31-2017 10-Q
17 02-28-2017 12-31-2016 10-K
18 11-03-2016 09-30-2016 10-Q
19 07-28-2016 06-30-2016 10-Q
20 05-03-2016 03-31-2016 10-Q
21 02-23-2016 12-31-2015 10-K
22 10-27-2015 09-30-2015 10-Q
23 08-06-2015 06-30-2015 10-Q
24 05-05-2015 03-31-2015 10-Q
25 02-24-2015 12-31-2014 10-K
26 10-30-2014 09-30-2014 10-Q
27 08-11-2014 06-30-2014 10-Q
28 05-06-2014 03-31-2014 10-Q
29 03-11-2014 12-31-2013 10-K
30 11-12-2013 09-30-2013 10-Q
31 08-07-2013 06-30-2013 10-Q
32 05-08-2013 03-31-2013 10-Q
33 03-14-2013 12-31-2012 10-K
34 11-08-2012 09-30-2012 10-Q
35 08-07-2012 06-30-2012 10-Q
36 05-10-2012 03-31-2012 10-Q
37 03-21-2012 12-31-2011 10-K
38 11-14-2011 09-30-2011 10-Q
39 08-15-2011 06-30-2011 10-Q
40 05-13-2011 03-31-2011 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

    Before 10 a.m. ET Friday, 108 stocks made new 52-week highs.

 the-daily-biotech-pulse-fda-nod-for-astellas-seagen-gilead-get-positive-regulatory-tidings-from-europe-3-ipos

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

    Thursday morning saw 23 companies set new 52-week highs.

 the-daily-biotech-pulse-mercks-keytruda-gets-label-expansion-in-europe-pfizer-to-sell-chinese-biologics-unit-celcuity-spikes

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 btig-downgrades-genmark-diagnostics-to-neutral

BTIG analyst Sung Ji Nam downgrades GenMark Diagnostics (NASDAQ:GNMK) from Buy to Neutral.

 cowen--co-downgrades-genmark-diagnostics-to-market-perform-raises-price-target-to-2405

Cowen & Co. analyst Doug Schenkel downgrades GenMark Diagnostics (NASDAQ:GNMK) from Outperform to Market Perform and rai...

 3-cancer-diagnostic-stocks-to-watch-following-roches-genmark-buy

Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a

 canaccord-genuity-downgrades-genmark-diagnostics-to-hold

Canaccord Genuity analyst Max Masucci downgrades GenMark Diagnostics (NASDAQ:GNMK) from Buy to Hold.

 the-daily-biotech-pulse-fulgent-nabs-cdc-contract-enzo-rallies-solid-biosciences-releases-gene-therapy-data-moderna-begins-pediatric-vaccine-study

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 65-biggest-movers-from-yesterday
65 Biggest Movers From Yesterday
03/16/2021 10:29:13

Gainers

Core News & Articles

Toward the end of trading Monday, the Dow traded up 0.15% to 32,829.24 while the NASDAQ rose 0.65% to 13,406.57. The S&P al...

Core News & Articles

Gainers Rubius Therapeutics, Inc. (NASDAQ: RUBY) shares jumped 102.6% to $33.29 after the company reported initial clinical ...

Core News & Articles

Midway through trading Monday, the Dow traded down 0.01% to 32,776.65 while the NASDAQ rose 0.31% to 13,361.69. The S&P als...

 needham-downgrades-genmark-diagnostics-to-hold

Needham analyst Mike Matson downgrades GenMark Diagnostics (NASDAQ:GNMK) from Buy to Hold.

Core News & Articles

Following the market opening Monday, the Dow traded up 0.02% to 32,783.87 while the NASDAQ rose 0.28% to 13,357.04. However, th...

Core News & Articles

    On Monday morning, 415 companies achieved new highs for the year.

 32-stocks-moving-in-mondays-pre-market-session

Gainers Acer Therapeutics Inc. (NASDAQ: ACER) shares rose 87.1% to $6.38 in pre-market trading. Acer Therapeutics, earlier d...